This inventor holds 9 USPTO granted patents and 1 EPO patent. Top assignees: Supernus Pharmaceuticals, Inc., Dsm Fine Chemicals Austria Nfg Gmbh & Co. Kg, Chemie Linz Gesellschaft M.b.h.. Active years: 1994-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 1994-2021
Title: The Innovative Mind of Peter Hildebrand
Introduction
Peter Hildebrand is a distinguished inventor based in Linz, Austria, known for his significant contributions to the field of pharmaceuticals. With a portfolio of nine patents, he has demonstrated a remarkable ability to innovate in complex chemical processes.
Latest Patents
Among his latest patents, Peter has developed novel methods of producing molindone and its salts. This invention focuses on innovative synthesis techniques of molindone, including the production of its intermediates and high-purity compositions. Notably, his methods involve the use of the Mannich reaction, a strategic approach that showcases his expertise in pharmaceutical chemistry.
Career Highlights
Peter has worked with notable companies in the pharmaceutical industry, including Supernus Pharmaceuticals, Inc. and DSM Fine Chemicals Austria Nfg GmbH & Co KG. His experience in these organizations has provided him with a robust foundation in drug development and production, enabling him to create impactful pharmaceutical innovations.
Collaborations
Throughout his career, Peter has collaborated with talented professionals, including Martin Hanbauer and Zarghun Nazir. These partnerships have enhanced his research capabilities and contributed to the successful development of his patented inventions.
Conclusion
Peter Hildebrand's journey as an inventor highlights his commitment to advancing pharmaceutical sciences. With his innovative methods of producing molindone, he continues to pave the way for new possibilities in drug synthesis, demonstrating the vital role of inventors in shaping the future of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile